These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1293723)

  • 1. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A
    Trop Med Parasitol; 1992 Dec; 43(4):219-22. PubMed ID: 1293723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and chemical studies of Pera benensis, a Bolivian plant used in folk medicine as a treatment of cutaneous leishmaniasis.
    Fournet A; Angelo A; Muñoz V; Roblot F; Hocquemiller R; Cavé A
    J Ethnopharmacol; 1992 Sep; 37(2):159-64. PubMed ID: 1434690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A
    Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
    J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
    Macedo SR; de Figueiredo Nicolete LD; Ferreira Ados S; de Barros NB; Nicolete R
    Int Immunopharmacol; 2015 Sep; 28(1):554-9. PubMed ID: 26218282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.
    Fournet A; Ferreira ME; Rojas De Arias A; Torres De Ortiz S; Fuentes S; Nakayama H; Schinini A; Hocquemiller R
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2447-51. PubMed ID: 8913444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis.
    Peixoto JF; Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Finkelstein LC; Dias-Lopes G; Patricio BFC; Lima CGS; Rocha HVA; da Silva FC; Ferreira VF; Pereira BAS; Alves CR
    Int J Parasitol Drugs Drug Resist; 2024 Apr; 24():100525. PubMed ID: 38359731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-substituted quinoline alkaloids as potential antileishmanial drugs.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A; Bruneton J
    Antimicrob Agents Chemother; 1993 Apr; 37(4):859-63. PubMed ID: 8494383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
    Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
    J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
    Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
    J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
    Monzote L; García M; Montalvo AM; Linares R; Scull R
    Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
    Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC
    J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
    Rodrigues RF; Charret KS; da Silva EF; Echevarria A; Amaral VF; Leon LL; Canto-Cavalheiro MM
    Antimicrob Agents Chemother; 2009 Feb; 53(2):839-42. PubMed ID: 19015338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis.
    García Bustos MF; Barrio A; Prieto GG; de Raspi EM; Cimino RO; Cardozo RM; Parada LA; Yeo M; Soto J; Uncos DA; Parodi C; Basombrío MA
    J Parasitol; 2014 Dec; 100(6):840-7. PubMed ID: 25014108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.